Evaluating the 10X uncertainty factor for children and elderly with data-derived values for neuromuscular blocking agents

Human and Ecological Risk Assessment

Volumn 8, Issue 4, 2002, Pages 841-858

  Suh, Duck H ^a   Abdel Rahman, Mohamed S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Dynamics; Human sensitivity; Kinetics; Uncertainty factor

Indexed keywords

EID: 22344448181     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807030290879989     Document Type: Article

References (50)

1. Abdel-Megeed MA, Suh DH, Abdel-Rahman MS. 2001. Intra-species extrapolation in risk assessment of different classes of antimicrobials. Human Ecol Risk Asses 7:15-36
2. Alvarez-Gomez JA, Estelles ME, Fabregat J, et al. 1994. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients. Eur J Anaesth 11:53-6
3. Basta SJ, Savarese JJ, Ali HH, et al. 1988. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant. Anesth 69:478-86
4. Basta SJ, Dresner DL, Shaff LP, et al. 1989. Neuromuscular effects and pharmacokinetics of mivacurium in elderly patients under isoflurane anesthesia. Anesth Analg 68:S18
5. Bevan DR, Fiset P, Balendran P, et al. 1993. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 40:127-32
6. Bevan JC, Donati F, and Bevan DR. 1985. Attempted acceleration of the onset of action of pancuronium. Effects of divided doses in infants and children. Br J Anaesth 57:1204-8
7. Cook DR, Stiller RL, Weakly JN, et al. 1989. In vitro metabolism of mivacurim chloride (BW B1090U) and succinylcholine. Anesth Analg 68:452-6
8. Duvaldestin P, Saada J, Berger JL, et al. 1982. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesth 56:36-40
9. Fisher DM, Castagnoli KP, and Miller RD. 1985. Vecuronium kinetics and dynamics in anesthetized infants and children. Clin Pharmacol Ther 37:402-6
10. Fisher DM, Canfell PC, Fahey MR, et al. 1986. Elimination of atracurium in humans: Contribution of Hofmann elimination and ester hydrolysis versus organ based elimination. Anesth 65:6-12
11. Fisher DM, Canfell PC, Spellman MJ, et al. 1990. Pharmacokinetics and pharmacodynamics of atracurium in infants and children. Anesth 73:33-7
12. Gariepy LP, Varin F, Donati F, et al. 1993. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium. Clin Pharmacol Ther 53:340-7
13. Goudsouzian NG, Martyn JJA, Liu LMP, et al. 1984. The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children. Can Anaesth Soc J 31(3):246-50
14. Goudsouzian NG, Alifimoff JK, Liu LM, et al. 1987. The dose response of BW A938U in children. Anesth 67:A366
15. Goudsouzian NG, Alifimoff JK, Eberly C, et al. 1989a. Neuro-muscular and cardiovascular effects of mivacurium in children. Anesth 70:237-42
16. Goudsouzian NG, Alifimoff JK, Liu LM, et al. 1989b. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane. Br J Anaesth 62:263-8
17. Griffith HR and Johnson GE. 1942. The use of curare in general anesthesia. Anesth 3:418-20
18. IPCS (International Programme on Chemical Safety). 1994. Environmental Health Criteria No. 170: Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health Based Exposure Limits. World Health Organization, Geneva, Switzerland
19. Judge TG. 1973. The milieu interieur and ageing. In: Brucklehurst JC (ed), Textbook of Geriatric Medicine and Gerontology, pp 114-21. Churchill Livingstone, Edinburgh, UK
20. Katz JA, Fragen RJ, Shanks CA, et al. 1989. Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane. Anesth 70:432-6
21. Kent AP, Parker CJR, Hunter JM. 1989. Pharmacokinetics of atracurium and laudanosine in the elderly. Br J Anaesth 63:661-6
22. Kitt JB, Fisher DM, Canfell PC, et al. 1990. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesth 72:272-5
23. Koscielniak-Nielsen ZJ, Law-Min JC, Donati F, et al. 1992. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients. Anesth Analg 74:845-50
24. Lennon RL, Hosking MP, Houck PC, et al. 1989. Doxacurium chloride for neuromuscular blockade before tracheal intubation and surgery during nitrous oxide-oxygen-nartoic-enflurane anesthesia. Anesth Analg 68:255-60
25. Matteo RS, Backus WW, McDaniel DD, et al. 1985. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly. Anesth Analg 64:23-9
26. Matteo RS, Ornstein E, Schwartz AE, et al. 1993. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 77:1193-7
27. Meistelman C, Agoston S, Kersten UW, et al. 1986. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children. Anesth Analg 65:1319-23
28. Morris RB, Cahalan MK, Miller RD, et al. 1983. The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesth 58:438-40
29. Naumann BD, Silverman KC, Dixit R, et al. 2001. Case studies of categorical data-derived adjustment factors. Human Ecol Risk Assess 7:61-105
30. Nightingale DA and Bush GH. 1973. A clinical comparison between tubocurarine and pancuronium in children. Br J Anaesth 45:63-70
31. O'Kelly B, Fiset P, Meistelman C, et al. 1994. Pharmacokinetics of rocuronium bromide in paediatric patients. Eur J Anaesth 11:57-8
32. Ornstein E, Matteo RS, Schwartz AE, et al. 1992. Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients. Anesth Analg 74:841-4
33. Ostergaard D, Jensen FS, Jensen E, et al. 1992. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 36:702-6
34. Ostergaard D, Jensen FS, Jensen E, et al. 1993. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand 37:314-8
35. Pittet J, Tassonyi E, Morel DR, et al. 1989. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children. Anesth 71:210-3
36. Renwick AG. 1993. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Add Contam 10:275-305
37. Renwick AG and Lazarus NR. 1998. Human variability and noncancer risk assessment - An analysis of the default uncertainty factor. Regul Toxicol Pharmacol 27:3-20
38. Rowe JW, Andres R, Tobin JD, et al. 1976. The effect of age on creatinine clearance in mean: a cross-sectional and longitudinal study. J Gerontol 31:155-63
39. Rupp SM, Castagnoli KP, Fisher DM, et al. 1987. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesth 67:45-9
40. Savarese JJ, Ali HH, and Antonio RP. 1977. The clinical pharmacology of metocurine: Dimethyltubocurarine revisited. Anesth 42:277-84
41. Savarese JJ, Ali HH, Basta SJ, et al. 1988. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesth 68:723-32
42. Silverman KC, Naumann BD, Holder DJ, et al. 1999. Establishing data-derived adjustment factors from published pharmaceutical clinical trial data. Human Ecol Risk Assess 5:1059-89
43. Skowronski GA and Abdel-Rahman MS. 2001. Relevance of the 10X uncertainty factor to the risk assessment of drugs used by children and geriatrics. Human Ecol Rick Assess 7:139-52
44. Suh DH, Skowronski GA, Abdel-Rahman MS. 1999. The use of kinetic and dynamic data in risk assessment of drugs. Human Ecol Risk Assess 5:1091-121
45. Taivainen T, Meretoja OA, Erkola D, et al. 1996. Rocuronium in infants, children and adults during balanced anaesthesia. Paediatr Anaesth 6:271-5
46. Tomonaga M. 1977. Histochemical and ultrastructural changes in senile human skeletal muscle. J Am Geriatr Soc 25:125-31
47. nd ed, pp 744-819. Van Nostrand Reinhold, NY, USA
48. Wierda JMKH, Meretoja OA, Taivainen T, et al. 1997. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children. Br J Anaesth 78:690-5
49. Wynne HA, Cope LH, Mutch E, et al. 1989. The effect of age upon liver volume and apparent liver blood flow in healthy men. Hepatol 9:297-301
50. Xue F, Liu Q, Zou Q, et al. 1998. A comparative study of pharmacokinetics and pharmacodynamics of vecuronium in children and adults. Chinese Med J 111:84-5.